Oxford BioDynamics (LON:OBD) Shares Down 22.7% – Should You Sell?

Oxford BioDynamics Plc (LON:OBD) dropped 22.7% on Wednesday . The stock traded as low as GBX 1.40 ($0.02) and last traded at GBX 1.70 ($0.02). Approximately 4,144,623 shares traded hands during trading, an increase of 124% from the average daily volume of 1,847,190 shares. The stock had previously closed at GBX 2.20 ($0.03).

Oxford BioDynamics Stock Down 22.7 %

The company has a market cap of £5.30 million, a P/E ratio of -36.67 and a beta of 0.42. The company has a debt-to-equity ratio of 370.22, a current ratio of 0.68 and a quick ratio of 2.80. The business’s 50 day moving average price is GBX 1.82 and its 200-day moving average price is GBX 5.11.

Insider Activity at Oxford BioDynamics

In related news, insider David Holbrook bought 49,653 shares of the company’s stock in a transaction on Monday, October 28th. The stock was bought at an average cost of GBX 1 ($0.01) per share, with a total value of £496.53 ($629.16). Insiders own 16.78% of the company’s stock.

Oxford BioDynamics Company Profile

Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and the United Kingdom. The company provides EpiSwitch, a proprietary technology platform that enables screening, evaluation, validation, and monitoring of 3D genomic biomarkers to diagnose patients.